Altogether, the expression pattern of HMGB1 can be applied to the assessment of prognosis, chemotherapy efficacy and immune infiltration of breast cancer, which provides valuable clinical evidence for breast cancer treatment strategies targeting HMGB1. This evidence concerns the gene HMGB1 and breast carcinoma.